Connection

Paolo Gisondi to Treatment Outcome

Back to Details
This is a "connection" page, showing publications Paolo Gisondi has written about Treatment Outcome.
Paolo Gisondi
Connection Strength
0.126
Treatment Outcome
  1. Low incidence rate of respiratory and viral infections over 5 years of treatment with tildrakizumab in patients with moderate-to-severe psoriasis: pooled analysis from reSURFACE 1 and reSURFACE 2 phase 3 trials. J Eur Acad Dermatol Venereol. 2021 Nov; 35(11):e709-e711.
    View in: PubMed
    Score: 0.034
  2. Image Gallery: Pyoderma gangrenosum of the penis. Br J Dermatol. 2018 01; 178(1):e62.
    View in: PubMed
    Score: 0.027
  3. Infliximab biosimilar CT-P13 in the treatment of chronic plaque psoriasis: data from the Psobiosimilars registry. Br J Dermatol. 2017 12; 177(6):e325-e326.
    View in: PubMed
    Score: 0.027
  4. Ustekinumab does not increase body mass index in patients with chronic plaque psoriasis: a prospective cohort study. Br J Dermatol. 2013 May; 168(5):1124-7.
    View in: PubMed
    Score: 0.019
  5. Effectiveness of etanercept in children with plaque psoriasis in real practice: a one-year multicenter retrospective study. J Dermatolog Treat. 2018 May; 29(3):217-219.
    View in: PubMed
    Score: 0.007
  6. A Topical Treatment Optimization Programme (TTOP) improves clinical outcome for calcipotriol/betamethasone gel in psoriasis: results of a 64-week multinational randomized phase IV study in 1790 patients (PSO-TOP). Br J Dermatol. 2017 Jul; 177(1):197-205.
    View in: PubMed
    Score: 0.006
  7. Dose adjustment of biologic therapies for psoriasis in dermatological practice: a retrospective study. J Eur Acad Dermatol Venereol. 2017 May; 31(5):863-869.
    View in: PubMed
    Score: 0.006
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.